Hemlibra (Emicizumab) 30 mg/mL Injection
Hemlibra 30 mg/mL Injection is a prescription biologic medicine used for the prevention of bleeding episodes in patients with hemophilia A. It contains Emicizumab, a humanized monoclonal antibody that replaces the function of missing clotting factor VIII, helping the blood clot effectively and reducing spontaneous or recurrent bleeding episodes. It is used as a long-term preventive (prophylactic) therapy in hemophilia A patients, including those with or without factor VIII inhibitors.
Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition and Content
- Active Ingredient: Emicizumab
- Strength: 30 mg/mL
- Dosage Form: Subcutaneous injection (solution)
- Drug Class: Bispecific monoclonal antibody / Hemostatic biologic
How It Works
Hemlibra works by:
- Mimicking the function of clotting factor VIII
- Bridging activated factor IX and factor X
- Restoring normal blood clotting pathway
- Preventing spontaneous and repeated bleeding episodes
Unlike traditional factor replacement, it provides continuous protection.
Uses and Treatments
Hemlibra (Emicizumab) Injection is used for:
- Hemophilia A (congenital factor VIII deficiency)
- Hemophilia A with factor VIII inhibitors
- Hemophilia A without inhibitors
- Prevention of bleeding episodes
- Long-term prophylactic therapy
Dosage and How to Use
- Administered as a subcutaneous injection
- Given weekly, every 2 weeks, or monthly depending on prescription
- Initial loading dose followed by maintenance dosing
- Must be administered under medical supervision or trained healthcare provider
Important: Dosage is strictly individualized by a hematologist.
Advantages of Hemlibra
- Reduces frequency of bleeding episodes
- Effective in patients with or without inhibitors
- Long-lasting preventive protection
- Less frequent dosing than traditional factor VIII therapy
- Improves quality of life in hemophilia patients
Storage Conditions
- Store in refrigerator (2°C to 8°C)
- Do not freeze
- Keep in original carton to protect from light
- Do not shake
- Keep out of reach of children
Alternative Indian Brands / Options
As Emicizumab is a patented biologic, direct Indian generic alternatives are not available. However, hemophilia management options in India include:
- Factor VIII concentrates by Shire (Takeda Pharmaceuticals)
- Plasma-derived clotting factors by Reliance Life Sciences
- Recombinant clotting factor products by Bharat Serums and Vaccines
Note: Any therapy change must be supervised by a hematologist.
Buy Hemlibra Emicizumab 30 mg/mL Injection Online in the United States – Trusted Biologic Medicine Exporter
Looking to buy Hemlibra Emicizumab 30 mg/mL Injection in the United States of America? GlobMedIndia is a trusted international medicine exporter of biologic and hematology treatments, offering safe, genuine, and high-quality medicines with secure global delivery across United States.
We ensure reliable delivery across major US states and cities including California, Washington, Chicago, Los Angeles, Houston, Phoenix, Austin, Columbus, Philadelphia, San Antonio, San Diego, Dallas, and Jacksonville.
Why Choose GlobMedIndia?
- Trusted exporter of biologic medicines worldwide
- Cold-chain secure international shipping
- Fast and discreet delivery service
- 100% genuine and quality-assured products
- Reliable global healthcare supplier
- Buy Hemlibra Injection USA
- Emicizumab 30 mg/mL price USA
- Hemophilia A treatment USA
- Hemlibra supplier USA online
- Anti bleeding injection USA delivery
- Biologic medicine exporter USA
- GlobMedIndia hematology medicines
👉 Order Now for Fast, Safe & Secure Delivery Across the United States!
